landiolol has been researched along with Cardiovascular Stroke in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Fejér, C; Gellér, L; Kiss, B; Kovács, E; Merkely, B; Pilecky, D; Radics, P; Ruzsa, Z; Straub, É; Zima, E | 1 |
| Furuichi, Y; Sakamoto, A | 1 |
| Aoyagi, T; Hayami, N; Inaba, H; Kanamori, K; Kunishima, T; Mikamo, T; Murakawa, Y; Tsutsui, K | 1 |
| Doi, H; Endo, T; Ishigami, T; Ishikawa, T; Iwata, K; Kawashima, C; Kimura, K; Kiyokuni, M; Komura, N; Konishi, M; Mitsuhashi, T; Nakayama, N; Narikawa, M; Sakamaki, K; Sugano, T; Tomari, S; Yamanaka, T; Yano, H | 1 |
| Fujikawa, M; Iwasaka, J; Iwasaka, T; Oishi, C; Okazaki, T; Otani, H; Park, H; Sato, D; Ueyama, T; Yamamoto, Y; Yamashita, K | 1 |
| Abe, N; Hanada, K; Higuma, T; Kushibiki, M; Nishizaki, F; Oikawa, K; Okumura, K; Osanai, T; Saito, S; Sukekawa, T; Tomita, H; Yamada, M; Yokota, T | 1 |
| Yoshiyama, M | 1 |
| Hata, H; Hata, M; Kimura, H; Nakata, K; Sezai, A; Shiono, M; Unosawa, S; Wakui, S; Yoshitake, I | 1 |
| Iwasaka, J; Iwasaka, T; Noda, T; Okazaki, T; Otani, H; Park, H; Sato, D; Ueyama, T; Yamamoto, Y | 1 |
| Goyagi, T; Kimura, T; Masaki, Y; Nishikawa, T; Tobe, Y | 1 |
| Kanki, H; Mitamura, H; Ogawa, S; Sueyoshi, K; Takatsuki, S | 1 |
1 review(s) available for landiolol and Cardiovascular Stroke
| Article | Year |
|---|---|
[Perioperative cardiovascular evaluation and management for noncardiac surgery].
Topics: Adrenergic beta-Antagonists; Anesthesia; Atenolol; Bisoprolol; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Intraoperative Complications; Metoprolol; Monitoring, Intraoperative; Morpholines; Myocardial Infarction; Myocardial Ischemia; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Urea | 2014 |
2 trial(s) available for landiolol and Cardiovascular Stroke
| Article | Year |
|---|---|
Randomized study on the efficacy and safety of landiolol, an ultra-short-acting β1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Adrenergic beta-1 Receptor Antagonists; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Female; Humans; Injections, Intravenous; Male; Middle Aged; Morpholines; Myocardial Infarction; Prospective Studies; Stroke Volume; Treatment Outcome; Urea; Ventricular Remodeling | 2012 |
Intracoronary followed by intravenous administration of the short-acting β-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention.
Topics: Adrenergic beta-Antagonists; Aged; Elective Surgical Procedures; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Middle Aged; Morpholines; Myocardial Infarction; Percutaneous Coronary Intervention; Time Factors; Urea | 2013 |
8 other study(ies) available for landiolol and Cardiovascular Stroke
| Article | Year |
|---|---|
The application of landiolol in the cardiovascular and intensive care
Topics: Atrial Fibrillation; Critical Care; Heart Rate; Humans; Morpholines; Myocardial Infarction; Urea | 2022 |
Successful Treatment of Refractory Electrical Storm With Landiolol After More Than 100 Electrical Defibrillations.
Topics: Adrenergic beta-Antagonists; Aged, 80 and over; Coronary Angiography; Electric Countershock; Electrocardiography; Humans; Male; Morpholines; Myocardial Infarction; Tachycardia, Ventricular; Treatment Outcome; Urea | 2015 |
Beneficial effect of early infusion of landiolol, a very short-acting beta-1 adrenergic receptor blocker, on reperfusion status in acute myocardial infarction.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Myocardial Infarction; Myocardial Reperfusion; Percutaneous Coronary Intervention; Prospective Studies; Treatment Outcome; Urea | 2016 |
Efficacy of intracoronary administration of a short-acting β-blocker landiolol during reperfusion in pigs.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Vessels; Dose-Response Relationship, Drug; Injections, Intra-Arterial; Morpholines; Myocardial Infarction; Reperfusion Injury; Swine; Time Factors; Urea | 2011 |
Effect and safety of landiolol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Female; Humans; Male; Morpholines; Myocardial Infarction; Urea; Ventricular Remodeling | 2012 |
The effect of combined treatment with Impella(®) and landiolol in a swine model of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Combined Modality Therapy; Disease Models, Animal; Heart; Heart-Assist Devices; Male; Morpholines; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Swine; Treatment Outcome; Urea | 2012 |
Beta-adrenoreceptor antagonists attenuate brain injury after transient focal ischemia in rats.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics, Inhalation; Animals; Brain; Carbazoles; Carvedilol; Halothane; Ischemic Attack, Transient; Male; Morpholines; Myocardial Infarction; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Tetrazolium Salts; Urea | 2006 |
Salutary antiarrhythmic effect of combining a K channel blocker and a beta-blocker in a canine model of 7-day-old myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Drug Therapy, Combination; Electrocardiography; Female; Heart; Heart Ventricles; Male; Morpholines; Myocardial Infarction; Piperidines; Potassium Channel Blockers; Pyridines; Urea | 2000 |